Hudson Bay Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4M | Buy |
50,246
+405
| +0.8% | +$180K | 0.08% | 128 |
|
|
2025
Q1 | $24.2M | Buy |
49,841
+39,826
| +398% | +$19.3M | 0.07% | 129 |
|
|
2024
Q4 | $4.03M | Sell |
10,015
-19,985
| -67% | -$8.05M | 0.01% | 392 |
|
|
2024
Q3 | $14M | Sell |
30,000
-107,500
| -78% | -$50M | 0.06% | 140 |
|
|
2024
Q2 | $64.4M | Buy |
+137,500
| New | +$64.4M | 0.3% | 38 |
|
|
2024
Q1 | – | Sell |
-37,000
| Closed | -$15.1M | – | 787 |
|
|
2023
Q4 | $15.1M | Buy |
37,000
+30,000
| +429% | +$12.2M | 0.1% | 101 |
|
|
2023
Q3 | $2.43M | Buy |
+7,000
| New | +$2.43M | 0.02% | 381 |
|
|
2023
Q1 | – | Sell |
-32,000
| Closed | -$9.24M | – | 941 |
|
|
2022
Q4 | $9.24M | Buy |
+32,000
| New | +$9.24M | 0.09% | 173 |
|
|
2022
Q1 | – | Sell |
-32,500
| Closed | -$7.14M | – | 1288 |
|
|
2021
Q4 | $7.14M | Sell |
32,500
-30,000
| -48% | -$6.59M | 0.07% | 215 |
|
|
2021
Q3 | $11.3M | Buy |
62,500
+7,500
| +14% | +$1.36M | 0.15% | 98 |
|
|
2021
Q2 | $11.1M | Buy |
55,000
+2,200
| +4% | +$444K | 0.13% | 102 |
|
|
2021
Q1 | $11.3M | Buy |
52,800
+22,800
| +76% | +$4.9M | 0.14% | 97 |
|
|
2020
Q4 | $7.09M | Buy |
30,000
+20,000
| +200% | +$4.73M | 0.08% | 163 |
|
|
2020
Q3 | $2.72M | Buy |
+10,000
| New | +$2.72M | 0.04% | 300 |
|
|
2019
Q2 | – | Sell |
-14,000
| Closed | -$2.58M | – | 560 |
|
|
2019
Q1 | $2.58M | Buy |
+14,000
| New | +$2.58M | 0.03% | 243 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 597 |
|
|
2018
Q3 | – | Sell |
-30,000
| Closed | -$5.1M | – | 614 |
|
|
2018
Q2 | $5.1M | Hold |
30,000
| – | – | 0.07% | 143 |
|
|
2018
Q1 | $4.89M | Sell |
30,000
-20,000
| -40% | -$3.26M | 0.1% | 131 |
|
|
2017
Q4 | $7.49M | Hold |
50,000
| – | – | 0.16% | 70 |
|
|
2017
Q3 | $7.6M | Buy |
50,000
+10,000
| +25% | +$1.52M | 0.19% | 77 |
|
|
2017
Q2 | $5.16M | Buy |
40,000
+18,343
| +85% | +$2.36M | 0.1% | 111 |
|
|
2017
Q1 | $2.37M | Buy |
+21,657
| New | +$2.37M | 0.03% | 179 |
|